Growth Metrics

Cardio Diagnostics Holdings (CDIOW) Income towards Parent Company (2021 - 2025)

Historic Income towards Parent Company for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q3 2025 value amounting to -$1.7 million.

  • Cardio Diagnostics Holdings' Income towards Parent Company fell 2137.74% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.6 million, marking a year-over-year increase of 2061.01%. This contributed to the annual value of -$8.4 million for FY2024, which is 7.9% down from last year.
  • Latest data reveals that Cardio Diagnostics Holdings reported Income towards Parent Company of -$1.7 million as of Q3 2025, which was down 2137.74% from -$1.7 million recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Income towards Parent Company ranged from a high of -$397.0 in Q2 2021 and a low of -$4.2 million during Q1 2024
  • Moreover, its 5-year median value for Income towards Parent Company was -$1.4 million (2023), whereas its average is -$1.5 million.
  • As far as peak fluctuations go, Cardio Diagnostics Holdings' Income towards Parent Company plummeted by 21199017.63% in 2022, and later soared by 6798.35% in 2024.
  • Over the past 5 years, Cardio Diagnostics Holdings' Income towards Parent Company (Quarter) stood at -$144837.0 in 2021, then tumbled by 1541.89% to -$2.4 million in 2022, then skyrocketed by 41.59% to -$1.4 million in 2023, then fell by 9.39% to -$1.5 million in 2024, then decreased by 12.85% to -$1.7 million in 2025.
  • Its Income towards Parent Company stands at -$1.7 million for Q3 2025, versus -$1.7 million for Q2 2025 and -$1.6 million for Q1 2025.